Patent 9994443 was granted and assigned to SELECTA BIOSCIENCES INC on June, 2018 by the United States Patent and Trademark Office.
Provided herein are compounds and related composition and methods that may be used to raise an antibody response to nicotinic compounds, in some embodiments.